Google Ventures Backs Stem Cell Drug Company
iPierian Inc., a South San Francisco-based regenerative medicine company that uses induced pluripotent stem (iPS) cells, has raised $22 million in Series B funding. Google Ventures led the round, and was joined by Mitsubishi UFJ Capital, ATEL Ventures and return backers MPM Capital, Highland Capital Partners and Kleiner Perkins Caufield & Byers.
8 July 2010•3 mins read
